If your prices shift and your communication doesn’t, you risk looking evasive or, worse, deceitful. Labeling tariffs plainly ...

The FDA has said Novo Nordisk can add data showing that its Tresiba long-acting insulin can reduce risk hypoglycaemia to its label, amid fierce competition from cheaper alternatives.